http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 SAN DIEGO, June 5, 2008 -- In an editorial commentary(1) in the current issue of The Journal of Infectious Diseases (JID), independent experts on cytomegalovirus (CMV) said the vaccine under... http://pharmalicensing.com/redirs/news_rss//public/news/view/424323/4 http://pharmalicensing.com/redirs/news_rss//public/news/view/424323/4 EDMONTON, ALBERTA - June 5, 2008 - ViRexx Medical Corp. ("ViRexx" or the "Corporation") (TSX:VIR) (AMEX:REX) today announced that it has entered into a Standby Purchase Agreement ("Agreement") dated... http://pharmalicensing.com/redirs/news_rss//public/news/view/424322/4 http://pharmalicensing.com/redirs/news_rss//public/news/view/424322/4 June 02, 2008 -- NovaDel Pharma Inc. (AMEX: NVD) announced today that it completed the initial closing of $1,475,000 of its previously announced private placement of up to $4,000,000 in secured... http://pharmalicensing.com/redirs/news_rss//public/news/view/423543/4 http://pharmalicensing.com/redirs/news_rss//public/news/view/423543/4 June 3, 2008 - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announces today that it has raised C$5 M in share capital. http://pharmalicensing.com/redirs/news_rss//public/news/view/423943/4 http://pharmalicensing.com/redirs/news_rss//public/news/view/423943/4 Montreal, Canada, June 5, 2008 - CryoCath Technologies Inc. (TSX: CYT), today announced that the underwriters have exercised in part the over-allotment option granted to them in connection with... http://pharmalicensing.com/redirs/news_rss//public/news/view/424331/4 http://pharmalicensing.com/redirs/news_rss//public/news/view/424331/4